RCEL
AVITA Medical, Inc.NASDAQHealthcare$3.71-1.59%ClosedMarket Cap: $92.2M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
-6.77
P/S
1.29
EV/EBITDA
-2.04
DCF Value
$-27.54
FCF Yield
-33.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
82.1%
Operating Margin
-59.4%
Net Margin
-67.8%
ROE
476.6%
ROA
-95.7%
ROIC
676.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $17.6M | 81.2% | $-10.4M | $-11.6M | $-0.38 | — |
| FY 2025 | $71.6M | 82.1% | $-41.9M | $-48.6M | $-1.74 | — |
| Q3 2025 | $17.1M | 81.3% | $-9.2M | $-13.2M | $-0.46 | — |
| Q2 2025 | $18.4M | 81.2% | $-11.1M | $-9.9M | $-0.38 | — |
| Q1 2025 | $18.5M | 84.7% | $-11.8M | $-13.9M | $-0.53 | — |
| Q4 2024 | $18.4M | 87.6% | $-10.0M | $-11.6M | $-0.44 | — |
| FY 2024 | $64.3M | 85.8% | $-56.6M | $-61.8M | $-2.39 | — |
| Q3 2024 | $19.5M | 83.7% | $-13.8M | $-16.2M | $-0.62 | — |
| Q2 2024 | $15.2M | 86.1% | $-15.6M | $-15.4M | $-0.60 | — |
| Q1 2024 | $11.1M | 86.4% | $-17.2M | $-18.7M | $-0.73 | — |
| Q4 2023 | $14.2M | 87.3% | $-12.3M | $-7.1M | $-0.28 | — |
| FY 2023 | $50.1M | 84.5% | $-42.7M | $-35.4M | $-1.40 | — |